edetic acid has been researched along with Carcinoma, Non-Small Cell Lung in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bence, C; Cattet, F; Cohen, C; Heeke, S; Hofman, P; Hofman, V; Ilie, M; Lalvée, S; Leroy, S; Marquette, CH; Mouroux, J | 1 |
| Bach, S; Bahce, I; Bijnsdorp, IV; Bosschieter, J; Kazemier, G; Nieuwenhuijzen, JA; Novianti, PW; Rurup, WF; Segerink, LI; Steenbergen, RDM; van Moorselaar, RJA; van Splunter, AP | 1 |
| Cheng, D; Li, B; Lin, QY; Meng, L; Shi, H; Tan, H; Zhang, Y | 1 |
| Bui, C; Loh, H; Mansberg, R; Shetty, D; Stevanovic, A | 1 |
| Busby, E; Carey, D; Forero, A; Grizzle, WE; Khazaeli, MB; LoBuglio, AF; Meredith, RF; Robert, F; Shen, S | 1 |
| Eigenbrodt, E; Morr, H; Schneider, J; Velcovsky, HG; Weisse, G | 1 |
1 trial(s) available for edetic acid and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: effect of chelating agents and paclitaxel co-administration.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chelating Agents; Clinical Trials as Topic; Disease Progression; Edetic Acid; Female; Glycoproteins; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Paclitaxel; Pentetic Acid; Radioimmunotherapy; Radiometry; Thrombocytopenia; Treatment Outcome; Up-Regulation; Yttrium Radioisotopes | 2005 |
5 other study(ies) available for edetic acid and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Use of circulating tumor cells in prospective clinical trials for NSCLC patients - standardization of the pre-analytical conditions.
Topics: Adult; Carcinoma, Non-Small-Cell Lung; Cell-Free System; Clinical Trials as Topic; Edetic Acid; Female; Humans; In Situ Hybridization, Fluorescence; Lung Neoplasms; Male; Middle Aged; Neoplastic Cells, Circulating; Prospective Studies | 2018 |
A protocol for urine collection and storage prior to DNA methylation analysis.
Topics: Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; DNA; DNA Methylation; DNA, Neoplasm; Edetic Acid; Humans; Liquid Biopsy; Lung Neoplasms; Pilot Projects; Polymerase Chain Reaction; Preservation, Biological; Specimen Handling; Urinary Bladder Neoplasms; Urine Specimen Collection | 2018 |
Preliminary application of micro-SPECT/CT imaging by
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Edetic Acid; Glycine; Humans; Hydrazines; Lung Neoplasms; Male; Mice; Mice, Nude; Nicotinic Acids; Organotechnetium Compounds; Proto-Oncogene Proteins c-met; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Transplantation, Heterologous | 2019 |
Elevated 68Ga Prostate-Specific Membrane Antigen Activity in Metastatic Non-Small Cell Lung Cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Oligopeptides; Organometallic Compounds; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Tomography, X-Ray Computed | 2016 |
Quantitative detection of tumor M2-pyruvate kinase in plasma of patients with lung cancer in comparison to other lung diseases.
Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Enzyme Tests; Disease Progression; Edetic Acid; Enzyme-Linked Immunosorbent Assay; Humans; Isoenzymes; Lung Diseases; Lung Diseases, Obstructive; Lung Neoplasms; Neoplasm Proteins; Pneumoconiosis; Pyruvate Kinase; Sensitivity and Specificity; Tuberculosis, Pulmonary | 2000 |